RP vs. SIS Surgery for Stress Urinary Incontinence
Trial Summary
What is the purpose of this trial?
One in five women will undergo prolapse surgery in their lifetime, and there is a strong correlation between prolapse and urinary incontinence. Pelvic floor surgeons aspire to improve relevant quality of life outcomes for women with pelvic floor disorders while minimizing complications and unnecessary procedures. There has been an experience of disappointment and frustration when a patient returns following POP repair with new symptoms of Stress Urinary Incontinence (SUI) that she ranks as a greater disruption to her quality of life than her original vaginal bulge. While retropubic (RP) slings are considered to be the "gold-standard" referent for other slings with long-term outcomes data, they are associated with the highest risks of intra- and post-operative complications including bladder injury, bleeding, and post-operative voiding dysfunction. Single-incision slings (SIS) are the latest iteration in sling development that build upon the benefits of slings but avoid passage through the muscles of the inner thigh. The hypothesis for this study is that single-incision slings (Altis) are non-inferior to Retropubic mid-urethral slings when placed at the time of native tissue vaginal repair.
Research Team
Catherine Matthews, MD
Principal Investigator
Wake Forest University Health Sciences
Eligibility Criteria
This trial is for English-speaking women at least 21 years old with pelvic organ prolapse (POP) stage II or higher and symptoms of stress urinary incontinence. They must be able to consent, return for follow-ups, complete questionnaires, and are considering native tissue vaginal repair. Excluded are those with poorly-controlled diabetes, prior pelvic radiation or surgery for incontinence, serious diseases affecting study compliance, pregnancy plans within a year post-surgery, incarceration status, certain bladder issues or unwillingness to have a synthetic sling.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Retropubic (RP) Sling (Mid-urethral sling)
- Single-Incision Sling (SIS) (Mid-urethral sling)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Wake Forest University Health Sciences
Lead Sponsor
Dr. L. Ebony Boulware
Wake Forest University Health Sciences
Chief Medical Officer since 2022
MD from Duke University School of Medicine, MPH from Johns Hopkins Bloomberg School of Public Health
Dr. Julie Ann Freischlag
Wake Forest University Health Sciences
Chief Executive Officer since 2020
BS from University of Illinois, MD from Rush University
Foundation for Female Health Awareness
Collaborator